Objective: Vitamin D receptor (VDR) mediates vitamin D activity. We examined whether VDR expression in excised melanoma tissues is associated with VDR gene (VDR) polymorphisms.
Introduction
Cutaneous melanoma incidence continually increases in developed countries, particularly in fair-skinned individuals [1] [2] [3] [4] .
Recent data 5 indicated that prevalence of melanoma in Northern Italy is two fold higher than in Southern Italy and with Central Italy showing prevalence at intermediate level.
High incidence rates were particularly registered in the Northeast Friuli-Venezia Giulia region (19.6/100,000/year in men; 16.4/100,000/year in women) 6 , implying that geographically detailed studies should be performed regarding melanoma risk factors 7 .
Melanoma is the leading cause of mortality among skin cancer patients with low survival rates 8 . Although new therapeutic treatments are available 9 , early detection and surgery remain the main treatment options. Therefore, every new discovery on melanoma biological pathways presents opportunity in improving management and treatment options. Considerable preclinical and epidemiologic data suggest that vitamin D may play an important role in cancer functional SNP that extends lengths of the receptor protein from 424 to 427 amino acid residues. BsmI, ApaI, and TaqI polymorphisms are located in the 3′ terminal region of the VDR gene and do not affect protein sequence of the VDR receptor. FokI polymorphism is reported not to be in linkage disequilibrium with the other three polymorphisms. Instead, BsmI, ApaI, and TaqI polymorphisms are reported to be in linkage disequilibrium to a variable extent; thus, combined genotypes including two or three of these polymorphisms were investigated in literature 26, 28, 29 . Some evidence suggested that genotypes FF, BB, tt, and the combined genotype BBAAtt may be associated with increased expression of VDR, which in turn regulates actions of vitamin D [26] [27] [28] . Roles of VDR polymorphisms in melanoma were evaluated in some recent studies and meta-analyses [30] [31] [32] [33] [34] [35] [36] [37] . However, associations of VDR polymorphisms with skin cancer risk remain insufficiently characterized 30, 31, 36 .
At present, no study examined VDR polymorphisms and VDR expression in melanoma cells of excised tissues from patients.
Thus far, only one cohort of 69 Polish melanoma patients was investigated by two studies for VDR expression in tumor tissues 38, 39 . VDR expression progressively decreases from normal skin to melanocytic nevi to melanomas 38 , suggesting the relationship between VDR expression and melanoma prognosis 39 . Brożyna and colleagues 38 observed reduced expression levels of VDR in skin surrounding nevi and melanomas as opposed to normal skin.
Advances in melanoma treatment can be achieved through developments in understanding of melanoma risk factors, genomics, and molecular pathogenesis 31, 40 .
By immunohistochemical staining of primary cutaneous melanoma tissues, we investigated VDR expression in relation to characteristics, melanoma histological grading, and metastatic stage of patients. We also explored the association of four VDR SNPs-FokI-rs2228570 C>T located in exon 2, BsmI-rs1544410 G>A located in intron 8, ApaIrs7975232 T>G located in intron 8, and TaqI-rs731236 T>C located in exon 9-with VDR expression levels in cutaneous malignant melanoma tissues.
consent. The Udine Institutional Ethical Committee approved the study protocol in accordance to the Declaration of Helsinki.
Seventy-four (39 males, 35 females, age range: 29-82 years) unrelated patients (hospitalized or outpatients) who consecutively underwent surgical excision of cutaneous melanoma were enrolled based on a retrospective design. Inclusion criteria were as follows: melanoma different from that in in situ only, absence of mucosal melanomas, patient is a resident of Friuli-Venezia Giulia region (Northern Italy), and absence of major chronic diseases, such as autoimmune diseases, and type 1 diabetes.
Assessment of melanoma diagnosis and patient stage classification were performed by clinical/histological findings as described by Balch et al. 41 . For patients with multiple melanomas, we examined only the first main melanoma according to histological assessment of major primary tumor grading, and primary melanoma characteristics were accounted for study analyses.
Questionnaires were used to collect information from each participant; data obtained included demographic and lifestyle characteristics and medical and family history of melanoma. Body mass index (BMI) was determined by ratio of weight (kg) to squared height (m).
Immunohistochemical staining and evaluation of VDR expression
Slides stained with hematoxylin and eosin were reviewed for each case from formalin-fixed and paraffin-embedded blocks and were selected for VDR immunohistochemical staining. Immunohistochemistry was performed on 5 µm thick paraffin sections as follows: after dewaxing, rehydration and endogenous peroxidase quenching with 3% v/v H 2 O 2 in methanol for 15 min, antigen retrieval in 0.01 M citrate buffer at 98°C water bath for 40 min, application and incubation of primary antibody (VDR mouse monoclonal D-6, sc-13133, Santa Cruz Biotechnology, Texas, USA) at 1:200 dilution 1 h at room temperature 42, 43 , incubation with peroxidase-based EnVision+ /Horseradish peroxidase (Dako A/S, Glostrup, Denmark) for 30 min at room temperature, and treatment with diaminobenzidine for 3 min 44 . The sections were then counterstained with Mayer's hematoxylin, dehydrated, and mounted. VDR expression was evaluated on tumor cells (nuclear and cytoplasmic staining) of the whole section. Immunolabeled sections were viewed under Nikon Eclipse 80i light microscope at 25× magnification, and a semi-quantitative evaluation was performed to determine VDR expression levels in malignant melanoma cells (nuclear and cytoplasmic staining). Staining of sweat gland cells, which consistently showed strong and diffused positivity throughout all samples, was used as positive reference. The term "emboli" indicates tumoral invasion of vascular cells observed in slide specimens. Melanoma specimens were reviewed by two pathologists involved in the study but were unaware of all other clinical and molecular data during evaluation. Our categorization choices were based on the following considerations: A) when melanomas feature 100% VDR-positive cells, all tumor cells are possibly responsive to vitamin D stimulation; B) when 0% cells are positive for VDR expression, virtually all tumor cells do not respond to vitamin D stimulation; C) aside from extreme conditions, a cut off at median percentage of positive cells can be reasonably used for evaluating the half of samples with higher vs. the half of samples with lower VDR expression. Therefore, results were ranked based on percentage of cells positive for VDR expression (irrespective of staining intensity). Cytoplasmic VDR expression ranged from 0% to 100%, with a median value at 20.0%. We categorized variables as follows: 100% cytoplasmic VDR-expression-positive cells versus all remaining melanomas; >20% cytoplasmic VDR-expressionpositive cells (high VDR expression) vs. ≤20% positive cells (low VDR expression); and absent (0% positive cells) vs. present (>0% positive cells) VDR expression. Only 11 out of 74 cases (14.9%) showed nuclear VDR-positive immunostaining, and all these cases were categorized into >20% cytoplasmic VDR-expression-positive cells. Given the low number of melanoma specimens showing VDR expression detected in nuclei, this parameter was not further analyzed.
Determination of VDR gene polymorphisms
Determination of SNP VDR-FokI (C>T), VDR-BsmI (G>A), VDR-ApaI (T>G), VDR-TaqI (T>C) was performed as previously described 29,45 after extraction of genomic DNA from ethylenediaminetetraacetic-acid -venous blood samples 46 . Absence or presence of restriction site was denoted by a capital or lower letter, respectively: "F" and "f" for FokI, "B" and "b" for BsmI, "A" and "a" for ApaI, and "T" and "t" for TaqI endonucleases 28, 29 . FokI, BsmI, ApaI and TaqI polymorphisms of VDR were studied using previously tested primers 29, 45 
Statistical analysis
Kolmogorov-Smirnov test was used to assess normal data distribution. Percentage of VDR-positive cells by immunohistochemical staining was not normally distributed. Thus, median values and ranges were reported for this variable. Mann-Whitney U test was used to assess differences between groups. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to determine association of groups with different VDR expression and melanoma characteristics, alleles, genotypes, and combined genotypes. Our study was explorative as no previous investigation determined frequencies of VDR polymorphisms in melanoma patients according to immunohistochemical findings of VDR expression Prior to study enrolment, we evaluated that a number of 70 subjects fitted the 80% power at an alpha level of 0.05 to detect differences between high (above the median) and low VDR expression melanoma groups whether OR value equals 3 or more for a SNP site 47 . Deviation tests from Hardy-Weinberg equilibrium (HWE) were performed using a separate Chi-square distribution for each SNP 29 . Linkage disequilibrium (LD) between SNPs was determined as described 29 . Two-sided significance level was set at 0.05, and P values ≤ 0.10 were considered as a tendency to be significant. Statistical software SPSS (SPSS Inc., Chicago, IL, USA) was used for statistical analyses.
Results

VDR immunohistochemical staining
A significant variability in VDR immunohistochemical staining was observed in cytoplasm of melanoma cells, with 16 
Patients and melanoma characteristics according to VDR expression
All 74 (35 females and 39 males) cutaneous melanoma patients were white residents in Northern Italy. Average age at melanoma diagnosis was 52.1±12.7 years, with 27% (20/74) of patients exhibiting metastatic melanoma (i.e., stages III and IV), and all showed Clark level higher than Clark I invasion. Table 2 shows VDR polymorphism genotypes, alleles, and combined genotype frequencies in all 74 patients and in groups of melanomas categorized according to VDR immunohistochemical staining. Each VDR polymorphism of FokI, BsmI, ApaI, and TaqI was in HWE. FokI SNP was not in LD with other SNPs. BsmI was in LD with ApaI and TaqI, and ApaI was in LD with TaqI. Thus, for further analyses, we considered binary and ternary combination of genotypes comprising BsmI, ApaI and TaqI polymorphisms. As observed in other studies 26, 29 , not all theoretically possible binary and ternary combination of genotypes were observed; thus, Table 2 reports only combined genotypes with at least one confirmed finding.
Patient and melanoma characteristics according to VDR polymorphisms
Differences between VDR expression groups were not Breslow thickness, mm, mean ± SD TILs, tumor infiltrating lymphocytes. Table S3 ). 
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Discussion
In our study, VDR expression was predominantly assessed in cytoplasm of melanoma cells (79.7%, 59/74 cases), with few tumors (14.9%, 11/74 cases) displaying VDR positivity in the nucleus. Such findings partially contrast those of other studies performed in a Polish cohort of 69 patients with primary cutaneous melanoma (comprising 35 metastatic melanomas and that were classified as follows: 4 Clark I, 6 Clark II, 23 Clark III, 24 Clark IV, and 12 Clark V stage, where 30 were superficial-spreading, 37 were nodular, and two were acral lentiginous melanomas); these previous studies indicated VDR-positive nuclear immunostaining in 84.1% and cytoplasmic immunostaining in 66.7% of patients 38, 39 . The study by Brożyna et al. 39 , however, showed percentage of melanoma specimens with high nuclear staining at 17.4% (12/69), which is close to the percentage of nuclear staining in our study. Discrepancies between results of Brożyna et al. and our study probably arise from different antibodies employed 21 , diverse histological characteristics, and/or geographical/genetic backgrounds of melanomas in the respective studies. According to European cancer observatory data 3 , the estimated age standardized (European) incidence rate (per 100,000/year) of malignant cutaneous melanoma and mortality are 5.6 and 2.8 in Poland and 13.4 and 2.0 in Italy, respectively.
We further analyzed data regarding cytoplasmic VDR immunohistochemical staining. Once the cytoplasmic VDR binds with 1α, 25-dihydroxyvitamin D ligand, and adequate coreceptor protein, retinoid X receptor, it translocates to the nucleus, and by recruitment of coactivators and corepressors modulates transcription of target genes that encode proteins responsible for final activities induced by vitamin D hormonal signaling 18 . Consequently, absence or downregulation of VDR expression may present implications for vitamin D resistance in melanoma tissues 38,48,49 and potentially modulates effects of vitamin D supplementation on prevention therapy of melanoma patients 49,50 .
We did not observe effects of age at melanoma diagnosis and gender on VDR expression in cutaneous melanomas 45 . Roles of BMI and smoking were focuses of previous melanoma research 8, 25, 51 . In the present investigation, we did not observe the effects of BMI and smoking on VDR expression.
Consistent with studies performed by other authors on a Polish cohort 38,39 , we observed that stage I melanomas were more frequent in tumors with high than with low VDR expression. In our study, stage IIA invasion was particularly more frequent in melanomas lacking VDR expression than in melanomas showing VDR expression. However, we did not observe significant data in relation to metastatic stages III and IV. Causes of these findings will require further enlarged studies.
Overall, metastatic melanomas did not exhibit different VDR expression from non-metastatic melanomas. Such results agreed with observations of some studies 13, 20, 48 but contradicted the findings of other authors 38, 39 . Specific geographical/ethnic backgrounds possibly affected results. Thus, enlarged studies in subjects with different ethnicities should be performed in the future to substantiate this issue.
In our study, localization of melanoma on the body was unrelated with VDR expression. We only observed a tendency (P=0.093) for upper limb melanomas to be more frequent in tumors lacking VDR expression. Thus, despite the expected different exposures to sunlight and environmental factors of different parts of the human body, VDR expression in our study is not associated with body regions in which primary melanomas develop.
Lesion-specific characteristics did not correlate with VDR expression; these characteristics include ulceration, number of mitotic figures, regression, absence of TILs, non-brisk or brisk TILs, tumor emboli, and melanoma subtype (epithelioid and small cell). At variance, in Polish patients studied by Brożyna and colleagues 39 cytoplasmic VDR immunostaining was higher in group of brisk TIL-positive vs. that of absent and non-brisk TIL melanomas (P=0.01), and VDR expression was lower in melanomas with ulceration. We noted a tendency for higher frequency of superficial spreading (P=0.063) in melanomas with high than low VDR expression. Similarly, Brożyna and colleagues 38 observed higher VDR expression in superficially spreading than nodular melanomas.
Remarkably, VDR expression was related to tumor Breslow thickness and Clark levels in our Italian patients. Melanomas with a thickness below 1.00 mm were more frequently observed in cases with high than low VDR expression, whereas those with thickness of over or equal to 1.01 mm were more frequent in melanomas with low VDR expression. Clark level II (none of the studied melanomas presented a Clark I) was detected more frequently in melanomas with high than low VDR expression (P=0.025). Overall, such findings concur with previous data on Polish patients 38, 39 .
We observed that VDR expression was unrelated with the presence of multiple melanomas, additional non-melanoma skin cancers and non-skin cancers, and melanoma familiarity. To our knowledge, no previous study assessed these issues.
To our knowledge, our study was the first to investigate the relationship between VDR expression of human melanoma cells in excised tissues of patients and VDR polymorphisms. Out of four VDR polymorphisms investigated in our study, A number of combined genotypes in our study yielded significant findings according to VDR expression. The AaTT combined genotype was more frequent in melanomas with high than low VDR expression. Combined genotypes BbAA, bbAa, AATt, BbAATt, and bbAaTT were more frequent in 100% VDR-positive cells than <100% VDR-positive cells. The AATT combined genotype was much more frequent in subjects without VDR expression (20%) than in those with VDR expression (1.7%) (OR=14.5, P=0.025). No previous study investigated the relationship of VDR expression with VDR combined genotypes. Lack of VDR expression in excised melanoma tissues has been associated with reduced overall survival of patients 38, 39 . Therefore, melanoma prognosis may be influenced by carrying a VDR combined genotype associated to absent or reduced VDR expression. In our melanoma patients, AATT is a rare combined genotype with a frequency of 5.4%, which is similar to the recent finding in an Italian cohort of 518 non-oncological subjects (6.0%) 29 . Further enlarged studies are warranted to assess roles of ApaI, BsmI, and TaqI combined genotypes in VDR expression in melanomas and their prognosis.
Regulation of VDR abundance is an important modulation mechanism of cellular responsiveness to 1α, 25-dihydroxyvitamin D 10 . Mechanisms underlying regulation of VDR abundance include alterations in transcription rate of VDR gene and/or stability of VDR mRNA and epigenetic changes 14 59 .
Roles of vitamin D in skin cancers still require complete elucidation 10, 57 . All vitamin D actions virtually occur through VDR activation. Recent evidence shows that the effects of 1α, 25-dihydroxyvitamin D and VDR are mediated at least in part by cellular calcium levels; thus, calcium possibly contributes to the suppressive ability of VDR on skin cancer 10, 57 . Deletion of VDR notably results in an increased susceptibility to tumorigenesis and also reduces ability of keratinocytes to clear UVB-induced DNA mutations 57 . VDR can bind to thousands of VDREs on human genome and upor downregulate hundreds of genes 10, 30, 57 . Based on bioinformatic analysis, almost 15,000 sites in human DNA are bound by VDR, and 16%-21% of these putative binding sites are found at gene promoters 10, 57, 60 . Aside from classical VDRE-mediated mechanisms, increasing evidence point to regulatory contribution of several miRNAs 14,18,54 and long non-coding RNAs 10, 57 . A recent study on VDR cistrome demonstrated the unexpected complexity of gene regulation, which was examined on a genome-wide scale in target tissues and cells, including a cross-talk between VDR and immune factors 60, 61 . VDR expression is also commonly and significantly down regulated in colon adenocarcinoma. VDR cistrome analyses suggested that reduced VDR expression in colon cancer changes VDR activity by dampening expression of tumor suppressors by either stabilizing or inhibiting down regulation of oncogene expression. In turn, these effects may be associated with severe patient outcomes 62 . Thus, further research should study complex gene interactions and biological pathways related to vitamin D and melanoma and combine clinical evidence with molecular findings to support further progress 57,60,61 .
Limitations of our study include the limited number of patients and absence of data on circulating vitamin D levels in patients at the time of melanoma excision. Strengths of this research comprise genetic background restrictions of enrolled patients and determination of demographic, lifestyle, histological, and genetic characteristics.
Given the sample size and multiple comparisons of our study, a validation of independent datasets with larger samples, and multivariable analysis will be necessary to adjust genetic traits for age, sex, tumor location, sun exposure, and smoking. Serum sampling in future studies may also be performed to determine circulating levels of vitamin D at time of melanoma excision.
Conclusions
Current information insufficiently discusses influence of vitamin D oral supplementation to direct VDR modulatory effects in human skin cells, including melanocytes and keratinocytes. Our present findings support the necessity of further studies on this issue by combining clinical and molecular approach.
Our study showed that VDR expression is associated with prognostic parameters of tumor Breslow thickness and Clark level. However, VDR expression was not related to metastatic melanomas. Our immunohistochemical results concur with those of a previous study on VDR expression in colorectal cancer, showing that VDR was not associated with tumor location, stage, and grade 42 , and with another lung tumor study which demonstrated high variability of VDR expression 43 . Interestingly, we observed correlation between the Aa genotype and AaTT combined genotype with higher level of VDR expression and between AATT combined genotype and low or absent VDR expression; this new finding will require further validation. Future studies should assess whether VDR expression and VDR combined genotypes affect benefits of vitamin D and can drive an appropriate dose and schedule of calcitriol or other active (low calcemic) vitamin D analogs for melanoma treatment. Future set up of personalized nutrition and behavioral interventions will benefit from molecular studies exploring the connection of biological pathways to bioactive components of food and cancer 63 . Our study suggests that determination of VDR expression in excised tissues of melanoma and/or determination of VDR genotypes carriage can be used as personalized tool of precision medicine when considering melanoma patients. Breslow thickness, mm, mean ± SD 
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